本文へ移動

企業

Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc. の構造

Perspective Therapeutics, Inc.

企業

関連 4 件
上流供給と依存
自社製品と技術
関係の開始2026
Perspective Therapeutics, Inc.企業 · 関連 4 件
第 1 層

上流供給と依存3

自社製品と技術1

関係

矢印は関係の方向を示します。分野で絞り込めます。

  • Perspective Therapeutics, Inc.を使用 →Lead-212 (²¹²Pb)
    事実90%
    証拠を見る
    • 企業開示GlobeNewswire public company news2026-10-07 18:16
      The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
      出典を見る
  • Perspective Therapeutics, Inc.を使用 →Lead-212
    事実90%
    証拠を見る
    • 企業開示GlobeNewswire public company news2026-10-08 18:16
      The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
      出典を見る
  • Perspective Therapeutics, Inc.を製造 →Clinical drug product candidates
    事実90%
    証拠を見る
    • 企業開示GlobeNewswire public company news2026-10-08 18:16
      its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates
      出典を見る
  • 事実90%
    証拠を見る
    • 企業開示GlobeNewswire public company news2026-10-08 18:16
      its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates
      出典を見る

4 件中 1 から 4 件を表示

主張

出典とともに結論を確認し、項目を開いて証拠を読めます。

事実根拠 1
を使用Lead-212

The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

GlobeNewswire public company news · 2026-10-08 18:16

証拠を見る
  • 企業開示GlobeNewswire public company news2026-10-08 18:16
    The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
    出典を見る
事実根拠 1

its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates

GlobeNewswire public company news · 2026-10-08 18:16

証拠を見る
  • 企業開示GlobeNewswire public company news2026-10-08 18:16
    its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates
    出典を見る
事実根拠 1

its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates

GlobeNewswire public company news · 2026-10-08 18:16

証拠を見る
  • 企業開示GlobeNewswire public company news2026-10-08 18:16
    its proprietary <sup>224</sup>Ra/<sup>212</sup>Pb generator platform used to manufacture clinical drug product candidates
    出典を見る
事実根拠 1

The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

GlobeNewswire public company news · 2026-10-07 18:16

証拠を見る
  • 企業開示GlobeNewswire public company news2026-10-07 18:16
    The Company has proprietary technology that utilizes the alpha-generating isotope <sup>212</sup>Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
    出典を見る

4 件中 1 から 4 件を表示

市場とバリュエーション

バリュエーションは Pro と Research で利用できます。

Pro で解放

利用できません: 企業シグナル · 財務 · 開示資料 · ガイダンス